August 3, 2012 — In a bid to help control healthcare costs, on Oct 1, 2012, the Centers for Medicare and Medicaid Services (CMS) will stop paying hospitals for treating potentially avoidable surgical site infections following cardiac implantable electronic device (CIED) procedures. These include pacemaker and defibrillator implants.

 

 

August 3, 2012 — St. Jude Medical recently announced initial findings from the Riata lead evaluation study. The study’s phase I results found that externalized conductors occurred in 9.3 percent of the smaller-diameter Riata ST 7 French leads in the study, and in 24 percent of the larger-diameter Riata 8 French leads.

August 3, 2012 — GE Healthcare announced it has already received six orders for its Discovery IGS 730 system since receiving U.S. Food and Drug Administration (FDA) clearance in February 2012.

August 3, 2012 — FluoroPharma Medical Inc. announced that they have received high-quality images in an investigator-sponsored clinical trial in China where patients with coronary artery disease (CAD) were given BFPET, its imaging agent for measuring cardiovascular blood flow.

August 2, 2012 — According to new research published in the August issue of the Journal of Nuclear Medicine, single photon emission computed tomography/computed tomography (SPECT/CT) with 99mTc-hexamethylpropleneamine oxime-labeled white blood cells (99mTc-HMPAO-WBC) can improve the diagnosis of infectious endocarditis in hard-to-diagnose cases.

August 2, 2012 — Results of the ROMICAT II trial indicates coronary computed tomography (CT) angiography (CCTA) as a safe and time-efficient noninvasive modality to evaluate patients with chest pain in the emergency department (ED) when compared to the current standard approach.

August 2, 2012 — The Heart Rhythm Society (HRS) and the American College of Cardiology Foundation (ACCF) has released the HRS/ACCF Expert Consensus Statement on Pacemaker Device and Mode Selection, the first of its kind to specifically address pacemaker device and mode selection.

Subscribe Now